Published January 1, 2016 | Version v1
Journal article

Decreasing Irradiated Rat Lung Volume Changes Dose-Limiting Toxicity From Early to Late Effects

  • 1. Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen (Netherlands)
  • 2. Department of Cell Biology, University of Groningen, University Medical Center Groningen, Groningen (Netherlands)
  • 3. KVI Center for Advanced Radiation Research, University of Groningen, Groningen (Netherlands)

Description

Purpose: Technological developments in radiation therapy result in smaller irradiated volumes of normal tissue. Because the risk of radiation therapy-induced toxicity generally depends on irradiated volume, changing volume could change the dose-limiting toxicity of a treatment. Recently, in our rat model, we found that early radiation-induced lung dysfunction (RILD) was closely related to irradiated volume dependent vascular remodeling besides inflammation. The exact relationship between early and late RILD is still unknown. Therefore, in this preclinical study we investigated the dose-volume relationship of late RILD, assessed its dependence on early and late pathologies and studied if decreasing irradiated volume changed the dose-limiting toxicity. Methods and Materials: A volume of 25%, 32%, 50%, 63%, 88%, or 100% of the rat lung was irradiated using protons. Until 26 weeks after irradiation, respiratory rates were measured. Macrovascular remodeling, pulmonary inflammation, and fibrosis were assessed at 26 weeks after irradiation. For all endpoints dose-volume response curves were made. These results were compared to our previously published early lung effects. Results: Early vascular remodeling and inflammation correlated significantly with early RILD. Late RILD correlated with inflammation and fibrosis, but not with vascular remodeling. In contrast to the early effects, late vascular remodeling, inflammation and fibrosis showed a primarily dose but not volume dependence. Comparison of respiratory rate increases early and late after irradiation for the different dose-distributions indicated that with decreasing irradiated volumes, the dose-limiting toxicity changed from early to late RILD. Conclusions: In our rat model, different pathologies underlie early and late RILD with different dose-volume dependencies. Consequently, the dose-limiting toxicity changed from early to late dysfunction when the irradiated volume was reduced. In patients, early and late RILD are also due to different pathologies. As such, new radiation techniques reducing irradiated volume might change the dose-limiting toxicity of the radiation therapy treatment.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ijrobp.2015.09.034

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2015.09.034;
PII
S0360-3016(15)26533-9;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
94
Journal Issue
1
Journal Page Range
p. 163-171
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
48093660
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
FIBROSIS; INFLAMMATION; IRRADIATION; LUNGS; PATHOLOGY; RADIATION DOSE DISTRIBUTIONS; RADIATION HAZARDS; RADIOTHERAPY; RATS; TOXICITY
Descriptors DEC
ANIMALS; BODY; HAZARDS; HEALTH HAZARDS; MAMMALS; MEDICINE; NUCLEAR MEDICINE; ORGANS; PATHOLOGICAL CHANGES; RADIOLOGY; RESPIRATORY SYSTEM; RODENTS; SYMPTOMS; THERAPY; VERTEBRATES

Optional Information

Copyright
Copyright (c) 2016 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.